Developmental Therapeutics - Experimental Therapeutics Monday, June 7 at 8:00 AM - 12:00 PM
S Hall A2
#3080: A phase I/II study of oncolytic reovirus plus carboplatin/ paclitaxel in patients with advanced solid cancers with emphasis on squamous cell carcinoma of the head and neck (SCCHN).
Eleni M Karapanagiotou
Clinical Trials, Special Session - Trials in Progress Poster Session Monday, June 7 at 8:00 AM - 12:00 PM
S Hall A2
#TPS253: Phase I/II trial of reovirus serotype 3-Dearing strain in patients with recurrent ovarian cancer.
David E. Cohn, MD
#TPS292: Phase II study of reovirus with paclitaxel (P) and carboplatin (C) in patients with metastatic non-small cell lung cancer (NSCLC) who have Kras or EGFR-activated tumors.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.